Quarterly Earnings

A Pennsylvania marketing firm and its clients land on prestigious growth lists, proving a specialized strategy in trade industries is a powerful formula.

With international sales now making up nearly 60% of its revenue, the heavy industry giant is diversifying into humanoid robots and emerging markets.

HubSpot adds MongoDB CFO Mike Berry to its board, a strategic move to bolster financial discipline and guide its ambitious AI-driven global expansion.

As TI preps its Q1 2026 earnings call, all eyes are on its performance as an indicator for the industrial, auto, and broader semiconductor sectors.

With a massive profit jump, Vancity doubles down on community investment and branch expansion, challenging the Canadian banking industry's current trends.

The investment firm reports a 213% revenue surge after a major acquisition, but a 'going concern' note raises questions about its financial footing.

With a unique drug that preserves muscle while shedding fat, a newly fortified biotech is set to challenge the titans of the weight-loss market.

As Stryker preps its Q1 2026 report, all eyes are on whether the MedTech giant can sustain its momentum amid new products and industry-wide pressures.

Nexera Technologies reports 23% revenue growth while executing a bold strategic shift from online retail to the high-stakes AI homeland security market.

With tax refunds up 10%, experts offer a roadmap to turn that cash into real wealth, from debt reduction to hedging with gold. Here's how.

XPeng reports an 80% monthly sales jump but a yearly decline, while launching a major strategic expansion into Mexico and Latin America.

The energy firm's new agreement with Bahiagás boosts sales by 25% and fuels record production, signaling a profitable future in Brazil's evolving market.

A one-time gain gave the micro-cap a profitable quarter, but rising costs and reliance on a single large asset raise questions about its long-term stability.

Investors eye Alaska Air Group's Q1 results for insights on the Hawaiian Airlines integration, rising fuel costs, and shifting travel demand.

The biopharma firm touts transformative drug data ahead, but with cash for only month-to-month operations, its future hangs by a precarious thread.

With FDA approval, soaring revenues, and game-changing clinical data, InspireMD prepares to spotlight its CGuard Prime stent for investors this April.

Banking tech leader nCino posts record FY2026 results, fueling a major stock buyback and signaling deep confidence in its AI-driven global strategy.

Angel's Envy drops its annual Cask Strength Bourbon alongside a historic 10-Year Rye, a bold move in the booming ultra-premium whiskey market.

China's literary giant Yuewen leverages AI and a new generation of creators to build a global IP empire, from novels to AI-dramas and merchandise.

The logistics giant's global strategy pays off, with new regions turning a profit for the first time and Southeast Asia dominance solidifying its growth.